Literature DB >> 32036852

The Epidemiology of Acute Liver Failure.

Nina Weiler1, Andreas Schlotmann, Andreas Anton Schnitzbauer, Stefan Zeuzem, Martin-Walter Welker.   

Abstract

BACKGROUND: Acute liver failure (ALF) is a life-threatening event associated with high mortality. Currently, only estimates are available for its incidence. The aim of the study was to assess the incidence of ALF in Germany, using the accounting data of the largest statutory health insurance company, which represents 26.5 million people.
METHODS: The analysis included patients insured from 1 January 2014 to 31 December 2018. Coding with the International Statistical Classification of Diseases and Related Health Problems and the German operation and procedure codes were used to identify the patients, whose age, sex, liver transplantations (LT), and fatal outcomes were then recorded and extrapolated to the total population. As a validity check, the extrapolated LT results were compared with the LT that were actually performed.
RESULTS: The calculated incidence of ALF was 1.13/100 000 person-years, representing 4652 cases. Women were more often affected (52% versus 48%, p < 0.001). The overall rate of mortality within 3 months was 47%. A total of 203 LT were recorded in 176 patients. Men received 41% of the LT, women 59% (p < 0.137). The 1-year overall mortality rate after LT was 20%. The 203 calculated transplantations corresponded to 228 actually performed transplantations.
CONCLUSION: The incidence of ALF was higher than previously estimated for Germany, with only a very low rate of LT despite high mortality. When extrapolating ny, it must be borne in mind that those insured by the company concerned do not represent a valid sample.

Entities:  

Mesh:

Year:  2020        PMID: 32036852      PMCID: PMC7036472          DOI: 10.3238/arztebl.2020.0043

Source DB:  PubMed          Journal:  Dtsch Arztebl Int        ISSN: 1866-0452            Impact factor:   5.594


  35 in total

1.  Measuring, monitoring, and managing quality in Germany's hospitals.

Authors:  Reinhard Busse; Ulrike Nimptsch; Thomas Mansky
Journal:  Health Aff (Millwood)       Date:  2009-01-27       Impact factor: 6.301

2.  Germany: Health system review.

Authors:  Reinhard Busse; Miriam Blümel
Journal:  Health Syst Transit       Date:  2014

Review 3.  Acute liver failure: a life-threatening disease.

Authors:  Ali Canbay; Frank Tacke; Johannes Hadem; Christian Trautwein; Guido Gerken; Michael P Manns
Journal:  Dtsch Arztebl Int       Date:  2011-10-21       Impact factor: 5.594

4.  Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland.

Authors:  Einar S Björnsson; Ottar M Bergmann; Helgi K Björnsson; Runar B Kvaran; Sigurdur Olafsson
Journal:  Gastroenterology       Date:  2013-02-16       Impact factor: 22.682

5.  Nationwide survey for acute liver failure and late-onset hepatic failure in Japan.

Authors:  Masamitsu Nakao; Nobuaki Nakayama; Yoshihito Uchida; Tomoaki Tomiya; Akio Ido; Isao Sakaida; Osamu Yokosuka; Yasuhiro Takikawa; Kazuaki Inoue; Takuya Genda; Masahito Shimizu; Shuji Terai; Hirohito Tsubouchi; Hajime Takikawa; Satoshi Mochida
Journal:  J Gastroenterol       Date:  2017-10-13       Impact factor: 7.527

6.  Geographical variations in incidence, management and survival of hepatocellular carcinoma in a Western country.

Authors:  Nathalie Goutté; Philippe Sogni; Noelle Bendersky; Jean Claude Barbare; Bruno Falissard; Olivier Farges
Journal:  J Hepatol       Date:  2016-10-20       Impact factor: 25.083

7.  Drug-induced acute liver failure: results of a U.S. multicenter, prospective study.

Authors:  Adrian Reuben; David G Koch; William M Lee
Journal:  Hepatology       Date:  2010-10-14       Impact factor: 17.425

8.  Acute liver failure: redefining the syndromes.

Authors:  J G O'Grady; S W Schalm; R Williams
Journal:  Lancet       Date:  1993-07-31       Impact factor: 79.321

9.  Prognosis of autoimmune hepatitis showing acute presentation.

Authors:  Kazuhide Yamamoto; Yasuhiro Miyake; Hiromasa Ohira; Yoshiyuki Suzuki; Mikio Zeniya; Morikazu Onji; Hirohito Tsubouchi
Journal:  Hepatol Res       Date:  2012-10-22       Impact factor: 4.288

10.  Nationwide longitudinal analysis of acute liver failure in taiwan.

Authors:  Cheng-Maw Ho; Chih-Hsin Lee; Jann-Yuan Wang; Po-Huang Lee; Hong-Shiee Lai; Rey-Heng Hu
Journal:  Medicine (Baltimore)       Date:  2014-06       Impact factor: 1.889

View more
  6 in total

1.  Sex-linked differences in the course of thioacetamide-induced acute liver failure in Lewis rats.

Authors:  E Koblihová; I Mrázová; Z Vaňourková; H Maxová; M Ryska; J Froněk
Journal:  Physiol Res       Date:  2020-09-09       Impact factor: 1.881

2.  [Liver dysfunction in geriatric patients].

Authors:  Philipp Kasper; Frank Tacke; Hans Jürgen Heppner; Guido Michels
Journal:  Z Gerontol Geriatr       Date:  2022-09-01       Impact factor: 1.292

3.  Proteomics Indicates Lactate Dehydrogenase Is Prognostic in Acetaminophen-Induced Acute Liver Failure Patients and Reveals Altered Signaling Pathways.

Authors:  Joel H Vazquez; Stefanie Kennon-McGill; Stephanie D Byrum; Samuel G Mackintosh; Hartmut Jaeschke; D Keith Williams; William M Lee; Jonathan A Dranoff; Mitchell R McGill
Journal:  Toxicol Sci       Date:  2022-04-26       Impact factor: 4.109

4.  Application of Bone Marrow Mesenchymal Stem Cells Effectively Eliminates Endotoxemia to Protect Rat from Acute Liver Failure Induced by Thioacetamide.

Authors:  Ting Jiang; Geng Xia; Bo Yang; Hong-Wei Zhang; Yue-Shan Yin; Cheng-Wei Tang; Jin-Hui Yang
Journal:  Tissue Eng Regen Med       Date:  2022-02-05       Impact factor: 4.169

5.  In Vitro Differentiation of Human Amniotic Epithelial Cells into Hepatocyte-like Cells.

Authors:  Marcin Michalik; Patrycja Wieczorek; Piotr Czekaj
Journal:  Cells       Date:  2022-07-07       Impact factor: 7.666

6.  Magnesium Isoglycyrrhizinate Ameliorates Concanavalin A-Induced Liver Injury by Inhibiting Autophagy.

Authors:  Zihao Fan; Yuxian Li; Sisi Chen; Ling Xu; Yuan Tian; Yaling Cao; Zhenzhen Pan; Xiangying Zhang; Yu Chen; Feng Ren
Journal:  Front Pharmacol       Date:  2022-01-04       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.